MC
PLXP

Middleton & Co’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Middleton & Co’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,981
Closed -$21K – 157
2017
Q1 		$21K Hold
1,981
– – ﹤0.01% 153
2016
Q4 		$25K Buy
+1,981
New +$72.8K 0.01% 155

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
HWA
Heritage Way Advisors Rockford, Illinois $267M AUM 23.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Middleton & Co's PLXP Position: Q2 2017 in Review

Middleton & Co sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2017, closing a stake of 1,981 shares — an estimated $21K sold.

Middleton & Co first reported a position in PLXP in Q4 2016 and held it in 2 quarters. The position peaked at $25K in Q4 2016. 14 funds tracked by Wall St. Rank hold PLXP as of Q2 2017.

  • Middleton & Co reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Middleton & Co sold 1,981 PLx Pharma Inc. Common Stock shares in Q2 2017, an estimated $21K.
  • Middleton & Co first reported a position in PLx Pharma Inc. Common Stock in Q4 2016 and held it in 2 quarters.
  • Middleton & Co's PLx Pharma Inc. Common Stock position peaked at $25K in Q4 2016.
  • 14 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2017.

Based on Middleton & Co's 13F filing for Q2 2017, filed 18 Jul 2017.